Skip to main content
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
24.56
-0.08 (-0.32%)
At close: Feb 27, 2026, 4:00 PM EST
24.53
-0.03 (-0.12%)
After-hours: Feb 27, 2026, 5:21 PM EST

ACADIA Pharmaceuticals Revenue

In the year 2025, ACADIA Pharmaceuticals had annual revenue of $1.07B with 11.87% growth. ACADIA Pharmaceuticals had revenue of $283.99M in the quarter ending December 31, 2025, with 9.39% growth.

Revenue (ttm)
$1.07B
Revenue Growth
+11.87%
P/S Ratio
3.91
Revenue / Employee
$1,638,387
Employees
654
Market Cap
4.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.07B113.71M11.87%
Dec 31, 2024957.80M231.36M31.85%
Dec 31, 2023726.44M209.20M40.45%
Dec 31, 2022517.24M33.09M6.83%
Dec 31, 2021484.15M42.39M9.60%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Corcept Therapeutics 761.41M
Amicus Therapeutics 634.21M
TG Therapeutics 616.29M
Ligand Pharmaceuticals 268.09M
NewAmsterdam Pharma Company 22.50M
Centessa Pharmaceuticals 15.00M
Crinetics Pharmaceuticals 7.70M
Revenue Rankings

ACAD News

More News